Form 4 for ANGO ANGIODYNAMICS INC
Accepted 2023-07-25 00:00:00 ET · period of report 2023-07-20 · accession 0001140361-23-036116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-25 | 2023-07-20+ | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $8.69 | -754 | 47.5K | -2% | -$6,554 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-20 | F | D | 359 | $8.74 | 47,904 | D | — | — | (F1) The exempt disposition of 359 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022. |
| 2 | Common | Common Stock | 2023-07-21 | F | D | 395 | $8.65 | 47,509 | D | — | — | (F2) The exempt disposition of 395 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021. |